Cancer Biology and Medicine

SJR Rank #1,613H-index: 78SJR: 1.888Best quartile: Q1Open AccessAPC: US$1,500Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Cancer Biology and Medicine

Country

China

Type

journal

SJR by Edition

2022202500.511.52

Subject Categories

  • Cancer ResearchQ1
  • OncologyQ1

Areas: Biochemistry, Genetics and Molecular Biology · Medicine

Most published research topics

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesCancer Genomics and DiagnosticsLung Cancer Treatments and MutationsFerroptosis and cancer prognosisImmune cells in cancerCancer Cells and MetastasisCAR-T cell therapy researchCancer-related molecular mechanisms researchCancer, Hypoxia, and Metabolism

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs080160240320

Documents per Year

2022202503570105140

Detailed Information

ISSN

2095-3941

SJR Best Quartile

Q1

Region

Asiatic Region

Citations per Document (2 years)

7.03

References per Document

3.64

Coverage

2012-2026

Scope

Cancer Biology & Medicine (ISSN 2095-3941) is a peer-reviewed open-access journal of Chinese Anti-cancer Association (CACA), which is the leading professional society of oncology in China. The journal quarterly provides innovative and significant information on biological basis of cancer, cancer microenvironment, translational cancer research, and all aspects of clinical cancer research. The journal also publishes significant perspectives on indigenous cancer types in China.

Metrics from SCImago Journal Rank 2025. View on SCImago